The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Unity Biotechnology Inc shares valued at $557 were sold by Ghosh Anirvan on Nov 04 ’24. At $1.29 per share, Ghosh Anirvan sold 432 shares. The insider’s holdings dropped to 75,893 shares worth approximately $0.2 million following the completion of this transaction.
Also, Sullivan Lynne Marie sold 136 shares, netting a total of over 175 in proceeds. Following the sale of shares at $1.29 each, the insider now holds 55,925 shares.
Before that, Nguyen Alexander Hieu had sold 149 shares from its account. In a trade valued at $192, the Chief Legal Officer traded Unity Biotechnology Inc shares for $1.29 each. Upon closing the transaction, the insider’s holdings decreased to 149 shares, worth approximately $63538.10999999999.
As published in their initiating research note from Rodman & Renshaw on August 22, 2024, Unity Biotechnology Inc [UBX] has been a Buy and the price target has been revised to $8. Analysts at Wedbush upgraded the stock from ‘”a Neutral”‘ to ‘”an Outperform”‘ outlook in a report released in mid November. As of January 04, 2022, ROTH Capital has increased its “Neutral” rating to a “Buy” for UBX. Earlier on November 10, 2021, Mizuho upgraded its rating. Their new recommendation was “a Buy” for UBX stock which previously was a “a Neutral”.
Analyzing UBX Stock Performance
During the last five days, there has been a surge of approximately 52.07%. Over the course of the year, Unity Biotechnology Inc shares have jumped approximately 163.21%. Shares of the company reached a 52-week high of $3.10 on 01/23/25 and a 52-week low of $1.01 on 01/02/25. A 50-day SMA is recorded $1.30, while a 200-day SMA reached $1.43. Nevertheless, trading volume fell to 2.06 million shares from 0.54 million shares the previous day.
Support And Resistance Levels for Unity Biotechnology Inc (UBX)
According to the 24-hour chart, there is a support level at 2.13, which, if violated, would cause prices to drop to 1.68. In the upper region, resistance lies at 3.06. The next price resistance is at 3.54. RSI (Relative Strength Index) is 78.95 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.43, which suggests the price will decrease in the coming days. Percent R is at 25.36%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
